Analyst Ratings for SciClone Pharmaceuticals (SCLN)

SCLN Rating Summary

SCLN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on SCLN
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $8.00 (+58.4%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
7/16/2013 Aegis Capital
» Updated 3/12/2014
Upgrade Buy
(Hold)
8.00
(N/A)
5.67 5.05 -10.93% Details
9/18/2012 BWS Financial Upgrade Buy
(Hold)
8.25
(N/A)
4.69 5.05 7.68% Details
Like SCLN Ratings? Also take a look at GSK, XON, SNY

SCLN Ratings News